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SpHyastatin was first identified as a new cationic antimicrobial peptide in hemocytes
of the mud crab Scylla paramamosain. Based on the amino acid sequences deduced,
it was predicted that this peptide was composed of two different functional domains,
a proline-rich domain (PRD) and a cysteine-rich domain (CRD). The recombinant
product of SpHyastatin displayed potent antimicrobial activities against the human
pathogen Staphylococcus aureus and the aquatic animal pathogens Aeromonas
hydrophila and Pseudomonas fluorescens. Compared with the CRD of SpHyastatin,
the PRD presented better antimicrobial and chitin binding activities, but both regions
were essential for allowing SpHyastatin complete antimicrobial activity. The binding
properties of SpHyastatin to different microbial surface molecules suggested that
this might be an initial and crucial step for performing its antimicrobial activities.
Evaluated using propidium iodide uptake assays and scanning electron microscopy
images, the antimicrobial mechanism of SpHyastatin was found to be prone to disrupt
cell membrane integrity. Interestingly, SpHyastatin exerted its role specifically on the
surface of S. aureus and Pichia pastoris whereas it directly killed P. fluorescens
through simultaneous targeting the membrane and the cytoplasm, indicating that
SpHyastatin could use different antimicrobial mechanisms to kill different species of
microbes. As expected, the recombinant SpHyastatin increased the survival rate of
crabs challenged with Vibrio parahaemolyticus. In addition, SpHyastatin could modulate
some V. parahaemolyticus-responsive genes in S. paramamosain.
Keywords: SpHyastatin, Scylla paramamosain, antimicrobial peptide, antimicrobial mechanism, membrane
permeabilization, immune protection
Abbreviations: AMP, antimicrobial peptide; CRD, cysteine-rich domain; LPS, lipopolysaccharides; LTA, lipoteichoic acid;
MBC, minimal bactericidal concentration; MIC, minimum inhibitory concentration; PI, propidium iodide; PRD, proline-rich
domain; qPCR, quantitative real-time PCR; SEM, scanning electron microscopy.
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INTRODUCTION
Antimicrobial peptides are widespread in microbes, plants and
animals and they serve as a first line of defense against pathogen
invasion (Lay and Anderson, 2005; Hancock and Sahl, 2006;
Goyal et al., 2013; Sun et al., 2014; Wang et al., 2015). Most
of them are cationic and amphipathic, but vary extremely in
length, structural property and antimicrobial activity spectra. To
successfully develop and effectively utilize the recombinant or the
synthetic product of a new AMP requires a clear understanding of
its antimicrobial characterization including the mechanisms and
functions. Although several forms of antimicrobial mechanisms
of AMPs are known, it is generally accepted that most AMPs
are prone to inhibit or kill varieties of pathogens by directly
altering or disrupting their cell membranes. The representatives
are magainin 2, protonectin and CPF-C1, which are shown to
kill bacteria by inducing membrane permeabilization (Jang et al.,
2012; Wang et al., 2013; Xie et al., 2014). In addition, some
AMPs, such as buforin II and Bac7, appear to penetrate the
cell membrane and exert antimicrobial activity by damaging
critical intracellular targets including nucleic acids, proteins
and even the ribosomes without lysing the cell membrane
(Bustillo et al., 2014; Mardirossian et al., 2014; Guida et al.,
2015). Interestingly, a recent study states that tachyplesin I
may act via different action modes to kill Escherichia coli and
Staphylococcus aureus (Hong et al., 2015), suggesting that some
AMPs might have more than one active method of attack against
different species of microbes. AMPs possess multi-functionality
except for their direct antimicrobial activities (Lai and Gallo,
2009; Smith and Dyrynda, 2015). They can also modulate host
gene expression, function in chemotaxis, induce/inhibit cytokine
production, etc. (Mookherjee et al., 2006; Lai and Gallo, 2009).
For instance, expression of an AMP, msrA3, in potato not only
provides resistance against Fusarium solani but also mitigates
plant defense responses and alters plant development (Goyal
et al., 2013). Shrimp anti-lipopolysaccharide factor suppresses
the production of proinflammatory cytokine in LPS-stimulated
cervical cancer HeLa cells, implying its anti-inflammatory effects
on mammalian hosts (Lin et al., 2013). Penaeus monodon
penaeidin acts as a cytokine that can promote granulocyte and
semi-granulocyte adhesion (Li et al., 2010), and participates in the
wound-induced inflammation response in P. monodon (Li and
Song, 2010). Thus, the multiple immunomodulatory reactions of
AMPs are thought of as potential enhancement of host defense
against invading infectious agents.
Structure-function associated studies show that some AMPs
have their specific antimicrobial domains, for instance, the active
histone regions including buforin I and parasin I are usually
derived from the N-terminal portion of histone (Kim et al., 2000;
Cho et al., 2002). Conversely, the activity of hepcidin relies on
its C-terminal CRD which is derived from the preprohepcidin
through propeptide convertase cleavage (Xu et al., 2008; Wang
et al., 2009). Nevertheless, a recently reported defensin identified
in Japanese horseshoe crab shows its activity in both the
N-terminal hydrophobic region and the cationic C-terminal
region, which are active against Gram-positive and -negative
strains, respectively (Kouno et al., 2008). In addition, some
truncated fragments of AMPs, such as Bac7 (1–23), PR-39 (1–
22), and arasin 1 (1–23), exert a very potent antimicrobial activity
in comparison with their entire peptides (Paulsen et al., 2013;
Veldhuizen et al., 2014; Guida et al., 2015). Therefore, study of the
structure-function association of an AMP would facilitate clearly
elucidating its antimicrobial mechanism.
Compared with in vitro investigation, in vivo functional and
mechanism studies of AMPs at molecular level are relatively
less studied. The difficulty is partly due to the actual effective
concentration of AMPs being much lower when measured in
physiological conditions than in vitro (Lai and Gallo, 2009). In
vivo efficacy and safety profiles of some AMPs are commonly
evaluated in mice in which, for example, the roles of VR3,
an arginine- and valine-rich-hairpin-like AMP, and pardaxin in
response to pathogen infection are well investigated in different
mouse models (Dong et al., 2012; Huang et al., 2014). Recently,
artificial challenge experiments using live pathogens are also used
in marine animals for evaluating the efficacy of an AMP in vivo.
The antimicrobial effects of LcLEAP-2A and LcLEAP-2C are
determined in large yellow croaker with the challenge of Vibrio
alginolyticus (Li et al., 2014). In addition, the antiviral activity of
mytilin derived fragments is evaluated in Litopenaeus japonicus
and Palaemon serratus injected with white spot syndrome virus
(WSSV) (Roch et al., 2008), as well as a study on epinecidin-1
carried out in zebrafish infected with Vibrio vulnificus (Pan et al.,
2011).
In recent years, marine-derived bioactive peptides have
attracted much attention for exploitation because of their
potential development of new antimicrobial agents. AMPs are
an important finding in this field. To date, more than 2,000
AMPs of different origins have been reported in the AMP
database (APD1) (Pushpanathan et al., 2013), but only several
AMPs have been identified in crabs since the first AMP
characterized in Carcinus maenas (Schnapp et al., 1996). In our
previous study, a new hyastatin-like gene (SpHyastatin) encoding
131 amino acids was screened from a subtractive suppression
hybridization cDNA library of Scylla paramamosain (Chen et al.,
2010). SpHyastatin showed a certain sequence homology with
the reported hyastatin which is an AMP identified in Hyas
araneus (Sperstad et al., 2009). The study on SpHyastatin greatly
attracted our attention to reveal its characteristics and biological
functions because of its potential importance in immune defense.
S. paramamosain possesses vital economic value, and is one of
the most important marine breeding crabs in China. Normally,
S. paramamosain is prone to suffering from pathogen infection,
especially bacterial infection which often causes high mortality
to the crabs. However, no effective immune control measure
has been established as yet. Therefore, clarifying the new
AMP SpHyastatin of S. paramamosain would provide us with
more immune knowledge on how this peptide exerts a role
against pathogenic invasion when the crabs are raised in a
complex marine environment. In our study, SpHyastatin was
successfully expressed in Pichia pastoris and its antimicrobial
activities against both aquatic animal and human pathogens
were determined in vitro. Following MIC assay, confocal laser
1http://aps.unmc.edu/AP/main.php
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scanning microscopy and SEM assays were employed to further
differentiate and evaluate its antimicrobial features on different
species of pathogens in vitro. In addition, the immune protective
and immunomodulatory functions in S. paramamosain conferred
by SpHyastatin were further investigated.
MATERIALS AND METHODS
Animals and Strains
All animal procedures were carried out in strict compliance with
the National Institute of Health Guidelines for the Care and
Use of Laboratory Animals and were approved by the animal
welfare and ethics committee of Xiamen University. Microbial
strains used in this study were listed in Supplementary Table S1.
P. pastoris GS115 was purchased from Invitrogen (USA). Other
strains were purchased from the China General Microbiological
Culture Collection Center.
Recombinant Expression of SpHyastatin
and Proline-Rich Domain SpHyastatin in
the Yeast P. pastoris
The recombinant product of SpHyastatin was generated by
cleaving the fusion protein scygonadin/SpHyastatin, expressed
in the yeast P. pastoris. The fragment inserted into the Pichia
expression vector pPIC9K (Invitrogen USA) consisted of the
mature peptide sequence of scygonadin (FJ769142), a flexible
peptide linker (Gly-Gly-Pro-Gly-Ser-Gly), an enterokinase
recognition site (Asp-Asp-Asp-Asp-Lys), and the mature
peptide sequence of SpHyastatin (JX228177). The sequences
encoding either mature scygonadin or SpHyastatin were
amplified using either a pair of primers SCY-F/SCY-R or
SpHyas-F/SpHyas-R as listed in Supplementary Table S2. Then,
the two PCR products were used as templates to amplify a
complete scygonadin/SpHyastatin covalently linked sequence
using primers SCY-F and SpHyas-R. The resulting recombinant
plasmid pPIC9K-scygonadin/SpHyastatin was transformed
into E. coli DH5α and verified by sequencing. 3 µg of the
recombination DNA plasmid of linearization by SacI was used
to transform P. pastoris cells using electroporation. A positive
clone was chosen for large-scale recombinant expression induced
with 0.5% methanol. The subsequent supernatant, containing
the secreted fusion peptide, was collected and dialyzed in PBS
(phosphate-buffered saline, pH8.0) before being purified using
immobilized metal affinity chromatography. The fusion protein
was cleaved using recombinant enterokinase (Novagen, USA) in
the ratio of 1 U/50 µg at 16◦C for 12 h. The second purification
for the target protein, SpHyastatin, was accomplished with
immobilized metal affinity chromatography. Finally, the
collected SpHyastatin was dialyzed in Milli-Q water and stored
at−80◦C for later use.
Specific primers SCY-F paired with SCY-R and SpHyas-N term
(Supplementary Table S2) paired with SpHyas-R were used to
amplify the cDNA fragments of scygonadin and PRD SpHyastatin
(the region from Tyr 1 to Arg 80 of the mature peptide) before
a scygonadin/PRD SpHyastatin covalently linked sequence was
obtained using primers SCY-F and SpHyas-R. The recombinant
PRD was expressed and purified using a procedure similar to
the one used for expression and purification of the recombinant
SpHyastatin.
Peptide Synthesis of the CRD
CRD SpHyastatin consisted of 35 amino acids (3.8 kDa)
as follows: SNCWARCPGYPNGDSLCCRQYGACCSTSYPV
PYKG. The chemically synthesized CRD SpHyastatin was
purified via reverse phase HPLC by the Invitrogen Trading Co.,
Ltd., Shanghai, China. The purity of the synthetic peptide was
determined to be over 95%. The peptide was dissolved in sterile
Milli-Q water and stored at−80◦C until use.
Antimicrobial Assays
A variety of microbial strains were used to test the antimicrobial
activities of the recombinant SpHyastatin, the PRD and the
synthetic CRD. Mueller–Hinton broth, Difco marine broth and
YPG medium were used for culturing the standard bacterial
strains, the marine bacteria and the yeasts, respectively. The
MIC and MBC (minimum bactericidal concentration) values
were determined in triplicate on separate occasions using
liquid growth inhibition assays (Bulet et al., 1993; Wang
et al., 2009). Mid-logarithmic phase cultures of microbes were
diluted in 10 mM NaPB (pH 7.2–7.4), and then approximately
104 CFU/well for bacteria and 103 CFU/well for yeast were
incubated with serially diluted peptide in the presence of the
corresponding broth in a 96 well flat-bottom tissue-culture plate.
Cultures were grown in the dark for 24 or 48 h at 28◦C without
shaking. The lowest protein concentration induced no visible
growth when compared with the negative control, and was
defined as the MIC value. Cultures with no visible growth were
then placed on appropriate media. The MBC was calculated as
the concentration that prevented growth of more than 99.9% of
microorganisms after incubation for 24 h at 28 or 37◦C.
Bactericidal Assay
Kill-curve studies, performed using S. aureus, were conducted
as previously described (Wang et al., 2009). The concentration
corresponding to 4 × MBC for recombinant SpHyastatin was
incubated with S. aureus as described above. At various time
points, 6 µL of the treated bacterial suspension was added to
10 mM NaPB, mixed and spread on nutrition broth agar. The
numbers of CFU were determined after incubation at 37◦C for
18–24 h. The percentage of CFU was defined relative to the CFU
obtained in the control (100% CFU at 0 min).
Preparation of Polyclonal Antibody
against SpHyastatin
Five BALB/C mice raised in the Animal Culture Centre
of Xiamen University were immunized with the collected
recombinant SpHyastatin to generate the antiserum. The initial
immunization was subcutaneously injected with 200 µg of
SpHyastatin mixed with Freund’s complete adjuvant. The second
injection was carried out after an interval of 2 weeks with
100 µg of SpHyastatin mixed with incomplete form Freund
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adjuvant. Subsequently, the booster immunizations were given
in the same way each week for three times in all. The blood
of mice was collected 6 days after the last boost and clotted
overnight at 4◦C, then centrifuged at 6000 g for 10 min at
4◦C to obtain the antiserum. The crude serum obtained was
purified using a Nab Spin Kit, 1 mL for Antibody Purification
(Thermo Scientific, USA) following the manufacturer’s protocol.
The titer, purity and specificity of the purified anti-SpHyastatin
antibody were analyzed using ELISA, SDS-PAGE and Western
blot.
Binding Properties of SpHyastatin to
Lipopolysaccharides and Lipoteichoic
Acid
SpHyastatin binding properties to cell wall components, LPS
(0127: B8, Sigma, USA) from E. coli and LTA (L2515, Sigma,
USA) from S. aureus were investigated using ELISA modified
from a previous method (Zhang et al., 2013). First, 50 µL
(3 µg) of LPS or LTA solution (prepared in 100 mM Na2CO3,
20 mM EDTA, pH 9.6) were coated on a flat bottom 96-well
ELISA plate. The content was heated at 60◦C for 2 h until the
water evaporated completely and the excess bacterial components
were then washed out with PBS. The plate was blocked with
5% (w/v) BSA in PBS for 1 h at room temperature prior
to incubation with serial dilutions of the purified SpHyastatin
(0–0.04 mg/mL, 100 µL/well). The samples were cultured
with 100 µL of anti-SpHyastatin antibody (1:1000 dilution,
100 µL/well) for 2 h before incubating with HRP-labeled
Goat Anti-Mouse IgG (1:1,000 dilution, 100 µL/well) for 1 h.
Subsequently, tetramethylbenzidine (100 µL/well) was added to
the plate, which was incubated at room temperature for 15 min.
The colorimetric reaction was then terminated by adding 1 M
H2SO4. Finally, the absorbance (450 nm) of each well was
detected using a multifunctional microplate reader (TECAN
GENios, Switzerland). The assays were made in triplicate.
Scatchard plot analysis was used to assess the binding results. The
binding parameters, apparent dissociation constant (Kd), and the
maximum binding (Amax) were determined using non-linearly
fitting as A= Amax [L]/(Kd+ [L]), where A is the absorbance at
450 nm and [L] is the protein concentration.
Chitin-Binding Assay
Ten microgram portions of the recombinant SpHyastatin, PRD
or the synthetic CRD were separately used to estimate chitin-
binding properties using a modified protocol (Yao et al., 2012).
Briefly, each peptide was reconstituted in 50 µL buffer (20 mM
Tris-HCl buffer pH 8.0, 20 mM NaCl), and incubated for 2 h at
4◦C with 1 mg chitin (Sigma, USA). After a 15 min centrifugation
at 4◦C, the supernatants containing unbound proteins were
recovered and boiled with 4× SDS-PAGE buffer, while the pellets
were washed five more times with 1 mL wash buffer (20 mM
Tris-HCl buffer pH8.0, 20 mM NaCl) and then boiled with
1 × SDS-PAGE buffer for analysis of the bound fraction. Finally,
the total, unbound and bound samples were subjected to 15%
SDS-PAGE and were detected through Western blotting using the
anti-SpHyastatin antibody.
Propidium Iodide (PI) Uptake Assay
The integrity of the microbial membrane treated with
SpHyastatin was determined by measuring the influx of
PI using a modified method described previously (Wang
et al., 2013). Briefly, the tested microbes were grown to mid-
logarithmic phase in the appropriate growth media. Aliquots of
microbial suspension (108 cfu/mL) were incubated with 100 mM
NaPB (blank) or 400 µg/mL SpHyastatin (a concentration of
supra-MBC of peptide) at a volume ratio of 1:1 at 30◦C for
2 h. The suspension was mixed with PI (100 µg/mL) followed
by incubation for 5 min at room temperature in the dark.
Fluorescent images were obtained with a multiphoton laser
scanning microscope (Zeiss Lsm 780 NLO, Germany).
SEM Examination of the Microbial
Membrane
The ability of SpHyastatin to alter the morphology of microbes
was visualized using SEM as described earlier (Wei et al., 2013).
Briefly, microbial suspensions were prepared and incubated with
SpHyastatin as described in the PI uptake assay. The cells were
then fixed with 2.5% glutaraldehyde for 3 h and washed three
times with 100 mM NaPB before being placed on a poly-L-
lysine coated glass slide at 4◦C for 30 min. The samples were
subsequently dehydrated with graded ethanol and tert-butyl
alcohol followed by freezing at 4◦C and lyophilized using the
critical point method. Finally, the cells were gold-coated and
observed with an FEI XL-30 Environmental Scanning Electron
Microscope (USA).
SpHyastatin Localization Studies
SpHyastatin localization studies were carried out based on
a previous report with slight modifications (Morita et al.,
2013). Briefly, SpHyastatin was incubated with microbial
suspensions as mentioned above. After being fixed with 4%
paraformaldehyde for 30 min and washed three times, microbial
cells were immobilized on a poly-L-lysine coated glass slide
at 4◦C for 30 min. The cells were treated with 0.1% Triton
X-100 for 10 min and then blocked in 10% goat serum
for 1 h at room temperature. After blocking, cells were
reacted with primary antibody anti-SpHyastatin overnight at
4◦C followed by incubation for 1 h, in the dark, with
Dylight 649 conjugated goat anti-mouse IgG (Multisciences,
China). Finally, DAPI (Invitrogen, USA) was used for bacterial
staining. The fluorescence of cells was observed with a
multiphoton laser scanning microscope (Zeiss Lsm 780 NLO,
Germany).
Evaluation of S. paramamosain Survival
When Challenged with Bacteria
Co-treated or Pre-treated with
SpHyastatin
To investigate the in vivo function of SpHyastatin, we performed
mortality comparison using S. paramamosain (averaging 40± 5 g
each) as described previously (Pan et al., 2011). Briefly, both
of the recombinant SpHyastatin and the pathogenic bacterium
Vibrio parahaemolyticus were reconstituted in 1 × PBS for
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FIGURE 1 | Characterization of the primary structure property of SpHyastatin. (A) Multiple sequence alignment of SpHyastatin with hyastatin from
H. araneus (ACQ76432) and penaeidin from L. vannamei (ABA55000) using Clustal X 1.83 software. (B) Comparison of primary structure of hyastatins and
penaeidins. Different colors represent different structure domains.
TABLE 1 | Antimicrobial and bactericidal spectra of SpHyastatin, PRD SpHyastatin and CRD SpHyastatin.
Microorganisms CGMCC SpHyastatin PRD SpHyastatin CRD SpHyastatin
No.a MICc (µM) MBCc (µM) MIC (µM) MBC (µM) MIC (µM)
Gram-negative bacteria
Escherichia coli 1.2389 >10 >10 >10 >10 >37
Vibrio prahaemloyticus 1.1615 >10 >10 >10 >10 >37
Vibrio alginolyticus 1.1833 >10 >10 >10 >10 >37
Vibrio harvryi 1.1593 >10 >10 >10 >10 >37
Vibrio fluvialis 1.1609 >10 >10 >10 >10 >37
Pseudomonas stutzeri 1.1803 0.63–1.25 0.63–1.25 2.5–5 >10 >37
Pseudomonas fluorescens 1.0032 1.25–2.5 5–10 2.5–5 2.5–5 25–37
Aeromonas hydrophila 1.2017 1.25–2.5 >10 >10 >10 >37
Shigella flexneri 1.1868 >10 >10 >10 >10 >37
Pseudomonas aeruginosa 1.0205 >10 >10 >10 >10 >37
Gram-positive bacteria
Bacillus subtilis 1.108 >10 >10 >10 >10 >37
Bacillus cereus 1.447 >10 >10 >10 >10 >37
Micrococcus luteus 1.634 1.25–2.5 1.25–2.5 >10 >10 25–37
Staphylococcus aureus 1.363 0.63–1.25 0.63–1.25 2.5–5 2.5–5 >37
Corynebacterium glutamicum 1.1886 1.25–2.5 5–10 >10 >10 25–37
Micrococcus lysodeikticus 1.0634 2.5–5 2.5–5 2.5–5 >10 >37
Yeast
Candida albicans 2.2411 >10 >10 >10 >10 NTd
Pichia pastoris GS115 Invitrogenb 2.5–5 5–10 >10 >10 NT
aCGMCC No. China General Microbiological Culture Collection Number.
bPichia pastoris GS115 was purchased from Invitrogen.
cThe values of MIC and MBC are expressed in this table as the interval [a]-[b], where [a] is the highest concentration tested at which microbial growth can be observed,
and [b] the lowest concentration yields no detectable microbial growth or causes 99.9% microorganisms growth inhibition (n = 3).
dNT, not tested.
the experiments. For co-treatment, the peptide (10 µg/crab)
was incubated with V. parahaemolyticus (2 × 107 CFU/crab)
at room temperature for 30 min and then injected into
the base of the right fourth leg of crabs. On the other
hand, the immune protection role of SpHyastatin was further
investigated by injecting 10 µg of peptide/crab 1 h before
the V. parahaemolyticus injection, and the survival rates were
recorded.
Quantification of Immune Gene
Expression after Treatment with Various
Stimuli
S. paramamosain was injected with PBS, V. parahaemolyticus
(2 × 106 CFU/crab), V. parahaemolyticus plus SpHyastatin
(10 µg/crab) or SpHyastatin alone. Hemocyte samples were
collected at 6, 12, 24, and 48 h post-injection and were utilized
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FIGURE 2 | Killing kinetics of S. aureus cells treated with recombinant
SpHyastatin. The percentage of CFU is defined relative to the CFU obtained
in the control (100% CFU at 0 min). Each bar represents the means ± SD of
three determinations (n = 3).
to extract total RNA using TRIzol Reagent (Invitrogen, USA).
The cDNA was synthesized using a PrimeScriptTM RT Reagent
Kit (Takara Biotechnology Co., Ltd., Dalian, China). qPCR
was carried out to determine the relative expression level of
the selected genes in a 7500 Real-Time PCR System (Applied
Biosystems, Carlsbad, CA, USA) within a 20 µL reaction volume
containing 10 µL of Power SYBR Green PCR Master Mix (Roche,
USA), 1 µL cDNA template, 5 pmol of each primer. The PCR
reactions were 50◦C for 2 min, 95◦C for 10 min, then 40 cycles
(15 s at 95◦C, 1 min at 60◦C). β-actin (GU992421), a stably
expressed reference gene, was quantified to normalize the relative
expression levels for selected genes. Specific qPCR products were
confirmed by analysis of melting curve. Only primers, listed
in Supplementary Table S2, with the amplification efficiencies
calculated within 90–110% were selected for evaluating the
relative expression profiles using the algorithm of the 2−11Ct
method (Arocho et al., 2006).
GenBank accession numbers for the gene sequences used
in the present study are as follows: SpToll: JQ327142; ALF2:
JQ069031; Crustin: EU161287; SOD: FJ774661; CAT: FJ774660;
GPx: JN565286; and Lysozyme: HQ158762. The sequences of
Spaetzle, Cactus and Dorsal were obtained from a transcriptome
of S. paramamosain (unpublished data). Three replicates were
performed, analyzing at least 5 crabs for each sample. One-
way analysis of variance (ANOVA) was used for statistical
analysis using SPSS 11.0 to determine the expression difference
within groups. Statistically significant levels were accepted at
P < 0.05.
RESULTS
Analysis of the Overall Peptide Structure
of SpHyastatin
Multiple sequence alignment (Figure 1A) revealed that a short
PRP-containing portion (TRPFPRP) located in the N-terminal
region was conserved across the amino acid sequences of
hyastatins and penaeidins. Six conservation Cys residues located
in the C-terminal of hyastatins arrayed almost the same as in
the shrimp penaeidins, and the Cys array of these peptides
is C1-(X2-3)-C2-(X9-10)-C3-C4-(X5)-C5-C6 (Gueguen et al.,
2006). Consequently, the identity of structure property between
hyastatins and members of the penaeidin families was noticeable
as shown in Figure 1B. Each contained a signal peptide and
a conserved C-terminal CRD. In addition, SpHyastatin had a
prolonged PRD, H. araneus hyastatin consisted of a Gly rich
region and a short PRD, while penaeidins contained only a
short PRD.
Antimicrobial Activity Assays
As shown in Supplementary Figures S1A,B, both SpHyastatin
and PRD SpHyastatin were successfully expressed in P. pastoris.
The antimicrobial and bactericidal activities (shown in the MIC
and MBC, respectively) of the recombinant SpHyastatin were
examined using a panel of microorganisms. The MIC and MBC
values obtained are summarized in Table 1. The SpHyastatin
protein displayed a broad antimicrobial spectrum, exhibiting
FIGURE 3 | Binding properties of SpHyastatin to bacterial or fungal associated molecules. (A) The binding affinity of SpHyasatin protein to LPS and LTA
tested under ELISA. Each point represents the mean ± SD (n = 3). (B) Chitin-binding capacity of SpHyastatin, PRD and CRD. The total, unbound and bound
fractions were separated using SDS-PAGE and analyzed with Western blot using anti-SpHyastatin as the first antibody.
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FIGURE 4 | Effect of SpHyastatin on the integrity of the microbial membrane. Exponential phase microbial cells suspended in NaPB were incubated for 2 h at
room temperature with SpHyastatin. Subsequently, the cells were treated with PI and observed using confocal laser scanning microscopy to analyze the integrity of
the microbial membrane.
potent activities against both Gram-positive (Micrococcus
luteus, S. aureus, Corynebacterium glutamicum, Micrococcus
lysodeikticus) and Gram-negative bacteria (Pseudomonas stutzeri,
Pseudomonas fluorescens, Aeromonas hydrophila) with MIC
values of 0.63–2.5 µM, as well as values of MBC lower than
10 µM. In addition, SpHyastatin showed antimicrobial activity
against P. pastoris GS115 with a value of MIC 2.5–5 µM.
The antimicrobial activity of the recombinant PRD and the
synthetic CRD was separately measured in comparison with
the identical target species spectrum obtained using the full-
length SpHyastatin. As shown in Table 1, PRD was active
in Gram-positive (S. aureus, M. lysodeikticus) and Gram-
negative bacteria (P. stutzeri, P. fluorescens) with MIC values
of 2.5–5 µM. Compared with the antimicrobial activity of the
SpHyastatin mature peptide, PRD gave higher or similar MIC
values toward the above four strains tested, but was ineffective
against the growth of A. hydrophila, C. glutamicum, M. luteus,
and P. pastoris GS115. CRD inhibited the growth of P. fluorescens,
M. luteus, and C. glutamicum only at high concentrations
(MIC= 25–37 µM).
Killing Kinetics of SpHyastatin in
S. aureus
The results of the time-killing kinetic assay employed to further
evaluate the bactericidal activity of SpHyastatin using a highly
sensitive strain of S. aureus are shown in Figure 2 and
reveal that when SpHyastatin was incubated with S. aureus at
4 × MBC for different time intervals, it killed 90% of the
bacteria after incubation for 4 h and destroyed all the bacteria
around 6 h.
Microbial Associated Molecule-Binding
Properties
The binding properties of SpHyastatin protein to different
microbial surface molecules as measured using ELISA are shown
in Figure 3A. SpHyastatin could bind tightly to LPS and
LTA, even at a very low concentration of 1.25 µg/mL. It was
also found that more SpHyastatin bound to immobilized LPS
and LTA as increasing amounts of the protein were added,
indicating that the binding of the protein for each molecule
was in a concentration dependent manner. Additionally,
Scatchard plot analysis showed that SpHyastatin bound to
LPS and LTA with apparent dissociation constants (Kd) of
5.58 × 10−6 M and 1.32 × 10−5 M. This result suggested
that SpHyastatin exhibited stronger binding activity with LPS
than with LTA. As shown in Figure 3B, SpHyastatin was
recovered in the bound fractions, indicating that it was
able to bind tightly to chitin. PRD alone displayed binding
properties similar to the entire molecule. On the contrary,
CRD could be detected only in the unbound supernatant,
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FIGURE 5 | Effects of SpHyastatin on the membrane morphology of
S. aureus, P. fluorescens, and P. pastoris by SEM. Microbes treated with
NaPB (left column, control) show a normal smooth surface, while those
treated with SpHyastatin (right column) reveal clear morphological changes.
thus denoting that CRD did not exhibit specific binding to
chitin.
The Uptake of PI into Microbes Induced
by SpHyastatin
In order to characterize the bactericidal mechanism of
SpHyastatin, a PI uptake assay was utilized in this work.
PI, a DNA-intercalating fluorescent dye, is commonly used
to evaluate compromised cell membrane permeability. As
shown in Figure 4, confocal laser scanning microscopy revealed
that almost all the microbial cells were fluorescently labeled
by PI after 2 h of incubation with SpHyastatin, with no
fluorescence being visualized in the control group. That is,
SpHyastatin may injure microbial membranes and induce the
uptake of PI.
SpHyastatin Induces Morphological
Changes in Microbes
In order to gain a better understanding of the interaction between
SpHyastatin and microbes, SEM was employed to observe
directly the morphological changes in the microbial membrane
after exposure to SpHyastatin (Figure 5). After SpHyastatin
treatment, the SEM images of S. aureus, P. fluorescens, and
P. pastoris showed a clearly rougher surface, even the emergence
of collapsed architecture, in contrast to the normal and smooth
surfaces of the untreated group.
Different Localization Sites of
SpHyastatin on Different Microbes
Immunofluorescence was used to determine the action site of
SpHyastatin against various microbes. Two different localization
patterns were observed from the confocal laser scanning
microscopy images (Figure 6). Fluorescence localization of
SpHyastatin pre-treated with S. aureus and P. pastoris was
present around the cellular membrane but absent inside the
cell. On the other hand, this peptide was observed localized
throughout the cell of P. fluorescens, which likely resulted from
the peptide penetrating the cell membrane and accumulating in
the cytoplasm.
SpHyastatin Increases S. paramamosain
Survival in V. parahaemolyticus Infection
In order to evaluate the in vivo protective activities of SpHyastatin
against V. parahaemolyticus infection, co- and pre-treated groups
were designed. As shown in Figure 7A, SpHyastatin could
delay the original infectious process when co-treated with
V. parahaemolyticus. Especially, the median-lethal time for the
peptide co-treatment injected group was 30 h, while that of
the PBS co-treatment injected group was 10 h. In addition,
S. paramamosain pre-treatment with SpHyastatin at 1 h prior
to V. parahaemolyticus infection exhibited a higher survival rate
than those of crabs pre-treated with PBS (P < 0.05) (Figure 7B).
SpHyastatin Modulating the
V. parahaemolyticus Infection-Mediated
Immune Gene Expression Profiles in
S. paramamosain
Quantitative real-time PCR revealed the effect of SpHyastatin
on the immune response to V. parahaemolyticus (Figure 8).
Compared to the PBS controls, the transcription levels of the
canonical component related to the Toll pathway including
Spaetzle, SpToll, Cactus, and Dorsal were increased at various
times during treatment with V. parahaemolyticus. However,
co-injection of SpHyastatin and V. parahaemolyticus obviously
attenuated V. parahaemolyticus mediated induction of the above.
Expression of antioxidant enzymatic genes, such as CAT, SOD,
and GPx were significantly decreased by SpHyastatin and
V. parahaemolyticus co-treatment compared with the bacterially
treated group. qPCR analysis further showed that the expression
of Crustin and ALF2 were obviously down-regulated in response
to pathogen injection, but co-treatment alleviated the pathogen-
mediated down-regulation of these two AMPs. On the contrary,
the expression of Lysozyme was greatly increased by pathogen
stimulation, while the enhancement was abrogated in the co-
treated group. It was clearly seen that SpHyastatin treatment
alone induced hardly any change in the level of gene expression
in any group.
DISCUSSION
In the study, SpHyastatin was characterized for the first time in
the marine crab S. paramamosain. SpHyastatin possessed both
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FIGURE 6 | Localization of SpHyastatin in S. aureus, P. fluorescens, and P. pastoris as seen using confocal laser scanning microscopy. Aliquots of
microbial cells were incubated with SpHyastatin for 2 h at room temperature and then used for immunofluorescence analysis. The cells in squares were magnified
images to show details of fluorescence localization. For the untreated cells, only merged images are shown.
FIGURE 7 | The ability of SpHyasrtatin to protect S. paramamosain from a lethal challenge by V. parahaemolyticus. (A) V. parahaemolyticus incubated
with SpHyasrtatin or PBS for 30 min at room temperature, and then injected into crabs. (B) Crabs were injected with SpHyastatin or PBS at 1 h prior to
V. parahaemolyticus infection (n = 30). The survival curve of each experimental group was analyzed using the Kaplan–Meier Log rank test.
PRD and CRD and shared a certain similarity with H. araneus
hyastatin (Sperstad et al., 2009) and some shrimp penaeidins
(O’Leary and Gross, 2006; Woramongkolchai et al., 2011). These
studies revealed that the domain of either PRD or CRD is
generally contributed to the antimicrobial activity of an AMP,
however, even with the similar domains of PRD and CRD the
antimicrobial activity are different among AMPs. The finding of
SpHyastatin with multi-domain structure attracted our attention
to further explore what antimicrobial feature of SpHyastatin
may have and is it unique or similar to that confirmed in
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FIGURE 8 | SpHyastatin effects on the V. parahaemolyticus infection-mediated immune gene expression profiles in S. paramamosain. Crabs were
divided into PBS, V. parahaemolyticus (B), SpHyastatin + V. parahaemolyticus (SpHyas + B) and SpHyastatin (SpHyas) groups. The expression levels of Spatzle,
SpToll, Dorsal, Cactus, Lysozyme, Crustin, ALF2, SOD, CAT, and GPx were evaluated using qPCR at 6, 12, 24, and 48 h post-injection. The results showed that the
injection of SpHyastatin into crabs could modulate the mRNA expression of the tested immune or antioxidant-associated genes in S. paramamosain with a
challenge of V. parahaemolyticus at 6, 12, 24, or 48 h post-injection, respectively. In particular, the individual expression level of eight tested genes except for Cactus
and ALF2 was significantly changed at 12 h post-injection. Each bar represents the means ± SD (n = 5). The same letters (a, b, c, d) indicate no significant
difference between groups and different letters indicate statistically significant differences between groups (P < 0.05) as calculated by one way ANOVA followed by
Tukey test. It was noted that only the means at each time point were compared for the denotation with the letters, whereas the means at different time points could
not be compared with one another.
other AMPs? The structure-activity studies demonstrated that
PRD SpHyastatin alone showed potent antimicrobial activity
with MIC values a little higher than SpHyastatin mature
peptide, while CRD SpHyastatin displayed a relative weak
antimicrobial activity. This meant that PRD together with CRD
were indispensable to confer upon SpHyastatin the optimum
antimicrobial activity as shown in the studies of H. araneus
hyastatin (Sperstad et al., 2009), arasin 1 (Paulsen et al.,
2013) and shrimp penaeidins (Cuthbertson et al., 2005). These
results from structure-activity studies suggested that the PRD
SpHyastatin was probably the target active region similar to
the previous studies of PRD Pen4 in Litopenaeus setiferus
and the PRD arasin 1 in H. araneus, which maintain a
lower but still potent antimicrobial activity in comparison
with the full-length peptide (Cuthbertson et al., 2004, 2005;
Paulsen et al., 2013). This result was somewhat different
from the reported rHyastatin-N-term which is ineffective at
concentrations up to 25 µM in all tests (Sperstad et al., 2009),
suggesting an association between the structure and function
for both AMPs. Similarly the PRD PEN3 from Litopenaeus
vannamei does not inhibit microorganism growth even at
concentrations >50 µM (Cuthbertson et al., 2005, 2008).
Apparently, SpHyastatin possessed the unique antimicrobial
structure of PRD which differentiated it from the homologous
hyastatin of H. araneus. The variability in the primary sequence
of PRD was likely to result in the different activity of both
peptides, since the CRD sequence was totally conserved in both
peptides.
The present study further proved that SpHyastatin could
bind to various anionic cell wall components such as LPS
and LTA present on the surface of Gram-negative and Gram-
positive bacteria owing to carrying a net positive charge. The
data provided the evidence that electrostatic attraction between
SpHyastatin and the bacterial surfaces was crucial for performing
antimicrobial activity. The chitin-binding studies showed that
PRD, together with the full-length SpHyastatin, had a strong
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association with chitin (a component of the fungal cell wall)
similar to that observed in the rHyastatin-N-term of H. araneus
(Sperstad et al., 2009). Conversely, CRD SpHyastatin, containing
a partial conservation of the chitin-binding motif similar to
Tachypleus tridentatus tachycitin (Suetake et al., 2002) and
Mytilus coruscus mytichtin-1 (Qin et al., 2014), did not present a
homogeneous chitin-binding property as the penaeidins, whose
antifungal activities are probably mediated by their COOH-
terminal domain (Destoumieux et al., 2000). Thus, we deduced
that the high affinity between PRD SpHyastatin and chitin
might be an initial and crucial step for further anti-P. pastoris
activity.
Among the reported antimicrobial mechanisms of AMPs,
one was the disturbance of the integrity of the cell membrane
resulting in the release of ions and metabolites and/or lysis of
the cell (Reddy et al., 2004; Yan et al., 2013). In our study,
SpHyastatin could induce the influx of PI into cells, indicative
of a membrane permeabilizing killing action. In addition, SEM
results directly presented evidence that SpHyastatin induced
morphological changes and eventually led to lysis of both bacteria
and fungi, which was in accordance with the results of the PI
uptake assays. Further observation using confocal laser scanning
microscopy showed that the behavior of SpHyastatin killing
P. fluorescens was similar to that of the NK-18 derived from
mammalian NK-Lysin and NKLP27 from Cynoglossus semilaevis,
all of which were able to target not only the cell membrane
but also the cytoplasm, followed by disturbance of the bacterial
membrane of the targeted cells (Hayes et al., 2013; Yan et al.,
2013; Zhang et al., 2014). Similarly, the plant AMP NaD1 kills
Candida albicans and Fusarium oxysporum by way of entry
into the microbial cytoplasm and membrane permeabilization
(van der Weerden et al., 2008; Hayes et al., 2013). Nonetheless,
it was interesting to note that SpHyastatin acted only on the
cell membrane of S. aureus and P. pastoris and thus shared a
similar cell-killing mechanism to magainin II that kills E. coli
via permeabilizing the cell membrane without penetrating it
(Matsuzaki, 1998). Sphistin, the N-terminus of crab histone
H2A, also induces microbial cell death solely by permeabilizing
target membrane other than penetrating cell membrane (Chen
et al., 2015). Obviously, the binding positions of SpHyastatin
on the tested microbial cells were distinct among S. aureus,
P. fluorescens and P. pastoris, whereas P. fluorescens exhibited
a lower degree of cell rupture than S. aureus and P. pastoris
(Figure 5). Our present findings indicated that SpHyastatin
was likely to exert different cell-killing mechanisms on different
species of pathogens, and a similar study reports that tachyplesin
I uses different modes of action against E. coli and S. aureus
(Hong et al., 2015). This interesting observation will lead
us to further investigate whether an AMP like SpHyastatin
could specifically alter its antimicrobial action against different
invading pathogens in vivo through its morphological adaptation
to the different cell surface structure, composition and properties
of Gram-negative bacteria, Gram-positive bacteria and fungi.
This would be a very important antimicrobial innate defense
strategy for marine crabs to maintain homeostasis in a complex
environment.
In the present study, the in vivo function of SpHyastatin
was characterized through bacterial challenge experiments.
As expected, the recombinant SpHyastatin was capable of
improving the survival rate of crabs against the deadly
pathogen V. parahaemolyticus, suggesting that this peptide
had a resistant property similar to hepcidin (TH) 2–3,
hepcidin 1–5 and epinecidin-1. These marine-derived AMPs
are able to enhance the survival of mice or fish to different
pathogenic challenges (Wang et al., 2010; Pan et al., 2011,
2012; Huang et al., 2013). The potential medicinal application
of marine-derived bioactive peptides as therapeutic agents
for both human and animal welfare is attracting much
attention (Ngo et al., 2012; Nasri and Nasri, 2013; Jain
et al., 2015). Our current study presented evidence that
SpHyastatin was more likely to be a potential prophylactic
agent, which could be used in aquaculture and veterinary
medicine.
As observed, SpHyastatin importantly conferred immune
protection against pathogenic infection in S. paramamosain
(Figure 7). In our study, we therefore further investigated
the immune effect of SpHyastatin on pathogenic infection.
As a result, we found that SpHyastatin could alleviate
V. parahaemolyticus-induced changes in the transcription levels
of both immune-associated genes (Spatzle, SpToll, Dorsal, Cactus,
Lysozyme, Crustin, and ALF2) and antioxidant-associated genes
(SOD, CAT, and GPx). As evidenced by the in vitro binding
activities to LPS and LTA in our study, SpHyastatin might be an
endotoxin-neutralizing protein that may contribute to interfere
with the initiation of LPS or LTA mediated signal transduction,
alter the expression profiles of immune mediators, and dampen
the potentially harmful pro-inflammatory responses such as
cationic peptide LL-37 (Hirata et al., 1994; Scott et al., 2002).
Such anti-inflammatory properties are demonstrated in several
other marine-derived AMPs, for example, shrimp and Limulus
anti-lipopolysaccharide factor (Battafaraono et al., 1995; Lin et al.,
2013), and Strongylocentrotus droebachiensis centrocin 1 (Bjorn
et al., 2012) inhibit the secretion of pro-inflammatory cytokines
on mammalian hosts. It was further interesting to note that
the cumulative mortality in crabs pre-treated with SpHyastatin
and bacterium was significantly decreased. The reason was
likely to be due to its anti-inflammatory activities while not
associated with its bacteriostatic property, since SpHyastatin
was not able to inhibit the growth of V. parahaemolyticus
in vitro.
In summary, the newly identified SpHyastatin in
S. paramamosain had potent antimicrobial activity. This
peptide can effectively kill microbes via a permeabilizing
mechanism and probably had different antimicrobial active
modes against different species of bacteria. The recombinant
SpHyastatin was likely to confer immune protective resistance
against pathogenic challenge in S. paramamosain with less
causing significant change in level of the mRNA expression
of all tested immune and antioxidant-associated genes.
SpHyastatin thus possessed some unique antimicrobial
features in comparison with other known AMPs in
crabs.
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FIGURE S1 | SDS-PAGE analysis of the purified SpHyastatin and PRD
SpHyastatin. (A) The purification steps of SpHyastatin. Lane M, molecular weight
marker; lane 1, sample taken from the culture of GS115/pPIC9K at 24 h (negative
control); lane 2, fusion protein scygonadin/SpHyastatin expressed in P. pastoris
after induction by methanol for 24 h; lane 3, fusion protein after purification; lane 4,
fusion peptide cleaved by enterokinase; lane 5, flow through fractions; lane 6,
purified SpHyastatin. (B) The purification steps of PRD SpHyastatin. Lane M,
molecular weight marker; lane 1, sample taken from the culture of GS115/pPIC9K
at 24 h (negative control); lane 2, fusion protein scygonadin/PRD SpHyastatin
expressed in P. pastoris after induction by methanol for 24 h; lane 3, fusion protein
after purification; lane 4, fusion peptide cleaved by enterokinase; lane 5, flow
through fractions; lane 6, purified PRD SpHyastatin.
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